(Q32090951)

6 July 2017

1 reference

title

Management of type 2 diabetes mellitus in the elderly: special considerations (English)

1 reference

6 July 2017

1 reference

Rosenstock J

1

1 reference

6 July 2017

publication date

1 January 2001

1 reference

6 July 2017

1 reference

6 July 2017

volume

18

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

31-44

1 reference

Thiazolidinediones: a new class of antidiabetic drugs

6 July 2017

cites work

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

New treatments for patients with type 2 diabetes mellitus

1 reference

12 December 2020

UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

1 reference

12 December 2020

Evening insulin strategy

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group

1 reference

12 December 2020

A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes.

1 reference

12 December 2020

Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors

1 reference

12 December 2020

Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas

1 reference

12 December 2020

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Diabetes in the elderly: diagnosis, pathogenesis, and therapy.

1 reference

12 December 2020

The 4S study. Implications for prescribing

1 reference

12 December 2020

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

12 December 2020

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

12 December 2020

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

12 December 2020

Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure.

1 reference

12 December 2020

Management of diabetes in the elderly: a clinical perspective

1 reference

12 December 2020

Glimepiride. A review of its use in the management of type 2 diabetes mellitus

1 reference

12 December 2020

An evaluation of new agents in the treatment of type 2 diabetes.

1 reference

12 December 2020

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review

1 reference

12 December 2020

Diabetes mellitus in the elderly.

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Clinical profile of the novel sulphonylurea glimepiride

1 reference

12 December 2020

Repaglinide, a novel, short-acting hypoglycemic agent for type 2 diabetes mellitus

1 reference

12 December 2020

Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old.

1 reference

12 December 2020

Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients

1 reference

12 December 2020

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

1 reference

12 December 2020

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.

1 reference

12 December 2020

10.2165/00002512-200118010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

6 July 2017

1047233320

0 references

1 reference